W

William E. Gillanders

Washington University in St. Louis

ORCID: 0000-0002-0465-3071

Publishes on Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies. 355 papers and 15k citations.

PubIndex Score82Top 18% · seniorHow it's scored

355Publications

15kTotal Citations

First publication: 1992First senior author: 1997

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers Breast Cancer Treatment Studies vaccines and immunoinformatics approaches Monoclonal and Polyclonal Antibodies Research

Top publicationsby citations

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion

Narendra V. Sankpal, William E. Gillanders|Breast Cancer Research|2011

Cited by 53

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion

Narendra V. Sankpal, William E. Gillanders|BMC Cancer|2021

Cited by 14

Cancer-Associated Mutations Reveal a Novel Role for EpCAM as an Inhibitor of Cathepsin-L and Tumor Cell Invasion

Narendra V. Sankpal, William E. Gillanders|Research Square|2020

Cited by 0